ShareValue scores for 301075.SHE: Valuation 35, Quality 26, Growth 31, Health 23.

301075.SHE
SZSE

Tibet Duo Rui Pharmaceutical Co.Ltd.

CN¥55.47(-0.41%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-11% to 10%
Valuation
35
Overvalued
Price vs Value
Quality
26
Weak
Business Strength
Growth
31
Weak
Revenue & Earnings
Health
23
Stressed
Financial Stability
Momentum
39
Bearish
Price Trend

Company Details

About

Tibet Duo Rui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical formulations, chemical intermediates, and peptide APIs in China. It offers fluid therapy, anesthesiology medication, analgesic medication, and first-aid medication products, as well as multiple electrolytes injection; sodium acetate ringer's injection. Tibet Duo Rui Pharmaceutical Co., Ltd. was founded in 2005 and is headquartered in Tibet, China. Address: Building 1, Tibet, China

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026